EDDING GENOR 06998Hong Kong Stock Exchange

1.7000.00%( +0.000 )
Closed: Oct 9 · Delayed · Hong Kong Stock Exchange
EDDING GENOR (06998) Company Profile - Company Info, Industry & Management - cibo

Company Information

Market
HKEX Main Board
Listing Date
2020-10-07
Industry
Innovative Drugs & Biologics
Fiscal Year End
Dec 31

Industry

Innovative Drugs & Biologics 0.02%
124 stocks in this industry
Down 52 Up 57
Industry RankingsValue (HKD)Rank
Revenue (Last FY)2.92B36/112
Net Profit (Last FY)468.20M26/125
ROE (Last FY)10.36%28/117

Change is the 2026-10-09 close against the previous close; the industry change is the equal-weighted average of its stocks. Sub-industry classification is maintained by cibo. Last FY is each company's latest annual report. Net profit is profit attributable to owners of the parent; ROE = net profit / closing equity attributable to owners. Non-HKD statements are converted at ECB reference rates.

Management

NamePosition
Ni Xin Executive Director
Han Shuhua Executive Director
David Guowei Wang Non-Executive Director
Yu Tieming Non-Executive Director
Xu Qing Independent Non-Executive Director
Chen Wen Independent Non-Executive Director
Zheng Jingjing Independent Non-Executive Director

Board list from the HKEXnews "List of Directors and their Role and Function", as of 2026-03-27.

About this page

This page shows EDDING GENOR (06998) company information, related securities, the price change distribution and in-industry rankings within its sub-industry, and the board of directors. Quotes come from HKEX Daily Quotations, financial metrics from each company's latest annual report, and the director list from HKEXnews.